Preventing second-generation complications due to Staphylococcus aureus.
Rahal
J J
JJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002404:Catheterization / Q000009:adverse effects*; D003428:Cross Infection / Q000517:prevention & control*; D006801:Humans; D011446:Prospective Studies; D018805:Sepsis / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013997:Time Factors
D000900:Anti-Bacterial Agents